Review: taking Buspirone and Seroquel xr together


Summary

Drug interactions are reported among people who take Buspirone and Seroquel xr together. This review analyzes the effectiveness and drug interactions between Buspirone and Seroquel xr. It is created by eHealthMe based on reports of 1,327 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Buspirone and Seroquel xr >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Buspirone

Buspirone has active ingredients of buspirone. It is often used in stress and anxiety. (latest outcomes from Buspirone 4,300 users)

Seroquel Xr

Seroquel xr has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. (latest outcomes from Seroquel xr 8,029 users)

On Jul, 20, 2016

1,327 people who take Buspirone, Seroquel Xr are studied.


Number of reports submitted per year:

Buspirone and Seroquel xr drug interactions.

Drug effectiveness over time:

Buspirone:
  • < 1 month: 0.0% - (0 of 10 people)
  • 1 - 6 months: 23.0% - (4 of 17 people)
  • 6 - 12 months: 10.0% - (1 of 10 people)
  • 1 - 2 years: 0.0% - (0 of 8 people)
  • 2 - 5 years: 0.0% - (0 of 7 people)
  • 5 - 10 years: 33.0% - (1 of 3 people)
  • 10+ years: 33.0% - (1 of 3 people)
  • not specified: 0.0% - (0 of 1 people)
Seroquel Xr:
  • < 1 month: 11.0% - (1 of 9 people)
  • 1 - 6 months: 31.0% - (5 of 16 people)
  • 6 - 12 months: 40.0% - (4 of 10 people)
  • 1 - 2 years: 45.0% - (5 of 11 people)
  • 2 - 5 years: 40.0% - (4 of 10 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Buspirone:
  • female: 14.0% - (5 of 34 people)
  • male: 8.0% - (2 of 25 people)
Seroquel Xr:
  • female: 41.0% - (14 of 34 people)
  • male: 29.0% - (8 of 27 people)

Drug effectiveness by age:

Buspirone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 4 people)
  • 20-29: 0.0% - (0 of 10 people)
  • 30-39: 14.0% - (2 of 14 people)
  • 40-49: 14.0% - (2 of 14 people)
  • 50-59: 18.0% - (2 of 11 people)
  • 60+: 16.0% - (1 of 6 people)
Seroquel Xr:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 4 people)
  • 20-29: 63.0% - (7 of 11 people)
  • 30-39: 40.0% - (6 of 15 people)
  • 40-49: 23.0% - (3 of 13 people)
  • 50-59: 38.0% - (5 of 13 people)
  • 60+: 20.0% - (1 of 5 people)

Most common drug interactions over time *:

< 1 month:
  • type 2 diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic nephropathy
  • neuropathy peripheral
  • diabetes mellitus
  • diabetic coma
  • type 1 diabetes mellitus
  • hypoglycaemia
  • hypoglycaemic coma
  • decubitus ulcer
1 - 6 months:
  • type 2 diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetes mellitus
  • diabetic nephropathy
  • decubitus ulcer
  • depression
  • suicide attempt
  • insomnia
  • type 1 diabetes mellitus
  • back pain
6 - 12 months:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • neuropathy peripheral
  • hyperglycaemia
  • dementia
  • fear
  • hallucination
  • diabetes mellitus inadequate control
  • major depression
  • paranoid personality disorder
1 - 2 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • neuropathy peripheral
  • suicidal ideation
  • obesity
  • depression
  • diabetic nephropathy
  • weight increased
  • hyperglycaemia
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • blood cholesterol increased
  • hyperglycaemia
  • neuropathy peripheral
  • hypoglycaemia
  • chest pain
  • diabetic neuropathy
  • pancreatitis
5 - 10 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • blood cholesterol increased
  • neuropathy peripheral
  • diabetes mellitus inadequate control
  • blood triglycerides increased
  • hyperglycaemia
  • pancreatitis
  • type 1 diabetes mellitus
10+ years:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • sleep apnoea syndrome
  • hypercholesterolaemia
  • obesity
  • urinary tract infection
  • neuropathy peripheral
  • renal failure
  • tardive dyskinesia
  • blood cholesterol increased
not specified:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • weight increased
  • suicidal ideation
  • neuropathy peripheral
  • pancreatitis
  • blood triglycerides increased

Most common drug interactions by gender *:

female:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • diabetic neuropathy
  • weight increased
  • diabetes mellitus inadequate control
  • obesity
  • neuropathy peripheral
  • blood triglycerides increased
  • suicidal ideation
male:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • neuropathy peripheral
  • blood cholesterol increased
  • diabetic nephropathy
  • hyperglycaemia
  • obesity
  • suicidal ideation
  • type 1 diabetes mellitus

Most common drug interactions by age *:

0-1:
  • diabetes mellitus
  • blood triglycerides increased
  • convulsion neonatal
  • feeling jittery
  • hypocalcaemia
  • pancreatitis
  • pancreatitis acute
  • type 2 diabetes mellitus
  • weight increased
  • abdominal distension
10-19:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • thrombocytopenia
  • glucose tolerance impaired
  • suicidal ideation
  • aggression
  • paranoia
  • mania
  • neuroleptic malignant syndrome
20-29:
  • type 2 diabetes mellitus
  • suicidal ideation
  • diabetes mellitus
  • mood swings
  • abdominal pain
  • vision blurred
  • back pain
  • dizziness
  • diplopia
  • drug abuse
30-39:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • blood cholesterol increased
  • diabetic neuropathy
  • neuropathy peripheral
  • diabetic nephropathy
  • pancreatitis
  • diabetic ketoacidosis
  • type 1 diabetes mellitus
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • blood cholesterol increased
  • neuropathy peripheral
  • diabetes mellitus inadequate control
  • hyperlipidaemia
  • blood triglycerides increased
  • hyperglycaemia
  • type 1 diabetes mellitus
50-59:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • neuropathy peripheral
  • hyperglycaemia
  • blood cholesterol increased
  • obesity
  • hyperlipidaemia
  • hypoglycaemia
60+:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • malaise
  • cardiac disorder
  • depression
  • confusional state
  • weight increased
  • adverse event
  • drug ineffective

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Buspirone and Seroquel xr?

Can you answer these questions?

More questions for: Buspirone, Seroquel xr

You may be interested in these reviews

More reviews for: Buspirone, Seroquel xr

On eHealthMe, Buspirone (buspirone) is often used to treat stress and anxiety. Seroquel xr (quetiapine fumarate) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.